Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease
Clinical trial NCT04455555 · COMPLETED
Trial details
- NCT number
- NCT04455555
- Sponsor
- Peking University Third Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2019-02-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.